SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 44 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $639,000 | +7000.0% | 1,129,108 | +8102.7% | 0.00% | – |
| Q1 2017 | $9,000 | -81.2% | 13,765 | -51.0% | 0.00% | – |
| Q3 2016 | $48,000 | +140.0% | 28,088 | +157.2% | 0.00% | – |
| Q2 2016 | $20,000 | -92.0% | 10,922 | -89.7% | 0.00% | – |
| Q1 2016 | $249,000 | +336.8% | 105,638 | +322.3% | 0.00% | – |
| Q4 2015 | $57,000 | +3.6% | 25,015 | +0.1% | 0.00% | – |
| Q1 2015 | $55,000 | +189.5% | 24,989 | +96.8% | 0.00% | – |
| Q4 2014 | $19,000 | -77.4% | 12,697 | -73.0% | 0.00% | – |
| Q3 2014 | $84,000 | -2.3% | 46,970 | -5.7% | 0.00% | – |
| Q2 2014 | $86,000 | -33.3% | 49,812 | -0.7% | 0.00% | – |
| Q1 2014 | $129,000 | +158.0% | 50,182 | +54.1% | 0.00% | – |
| Q4 2013 | $50,000 | – | 32,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
| Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
| MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
| Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
| BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
| Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
| HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |